Xylem Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value decreased by 37.0% to $29.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 23.7%, from $38.00M to $29.00M. Over 4 years (FY 2021 to FY 2025), Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value shows a downward trend with a -18.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Higher intrinsic value indicates that options are 'in-the-money,' which may signal higher future dilution and potential compensation expense.
This metric measures the total positive difference between the current market price of the company's stock and the exerc...
Commonly reported by large-cap firms with significant executive and employee stock option programs.
other_share_based_compensation_arrangement_by_share_base_69077c| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $122.00M | $113.00M | $102.00M | $44.00M | $32.00M | $43.00M | $83.00M | $66.00M | $129.00M | $69.00M | $97.00M | $80.00M | $63.00M | $59.00M | $40.00M | $38.00M | $43.00M | $58.00M | $46.00M | $29.00M |
| QoQ Change | — | -7.4% | -9.7% | -56.9% | -27.3% | +34.4% | +93.0% | -20.5% | +95.5% | -46.5% | +40.6% | -17.5% | -21.3% | -6.3% | -32.2% | -5.0% | +13.2% | +34.9% | -20.7% | -37.0% |
| YoY Change | — | — | — | — | -73.8% | -61.9% | -18.6% | +50.0% | +303.1% | +60.5% | +16.9% | +21.2% | -51.2% | -14.5% | -58.8% | -52.5% | -31.7% | -1.7% | +15.0% | -23.7% |